Pro- and anti-inflammatory cytokine profile

A pro- and anti-inflammatory cytokine profile represents the complex balance of signaling proteins that coordinate the body's immune response to injury or infection. Pro-inflammatory cytokines, including Tumor Necrosis Factor-alpha (TNF-alpha), Interleukin-1 (IL-1), and Interleukin-6 (IL-6), initiate and amplify the inflammatory cascade to eliminate pathogens (Source: StatPearls, NBK499840). Anti-inflammatory cytokines, such as Interleukin-10 (IL-10) and Transforming Growth Factor-beta (TGF-beta), serve to dampen this response, preventing excessive tissue damage and promoting resolution (Source: PubMed, PMID: 10713116). This profile is not a single molecular target but a diagnostic assessment of the inflammatory state. Dysregulation of this balance is a hallmark of various pathologies, including rheumatoid arthritis, inflammatory bowel disease, and life-threatening conditions like sepsis or cytokine storm syndrome (Source: NIH, PMC7195073). Pharmacological intervention typically involves using biologics to selectively inhibit specific pro-inflammatory components of the profile to restore immunological equilibrium. Monitoring this profile is crucial in clinical settings to evaluate the efficacy of anti-inflammatory therapies and to predict disease progression in critically ill patients.

Other names

Cytokine profileInflammatory cytokine panelCytokine signatureTh1/Th2/Th17 cytokine balanceInflammatory marker profile

Therapeutic agents do not target the profile as a whole but rather individual components; for example, monoclonal antibodies bind to and neutralize specific pro-inflammatory cytokines (e.g., TNF-alpha, IL-6) or block their respective receptors to inhibit downstream inflammatory signaling pathways (Source: PubMed, PMID: 17505139).